Clinical trial
Long-term Documentation on the Use of Apremilast in Patients With Psoriatic Arthritis in Practice Conditions
NCT03106051 is registered in ClinicalTrials.gov with Amgen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Long-term Documentation on the Use of Apremilast in Patients With Psoriatic Arthritis in Practice Conditions
- Lead sponsor
- Amgen
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 18, 2016
- Completion date
- August 12, 2020
- Enrollment
- 526 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.